精准医学是“考虑到每个人的基因、环境和生活方式的个体差异来预防和治疗疾病的新兴方法。”这种方法将允许医生和研究人员更准确地预测哪种治疗和预防策略对于某一特定疾病和在哪些人群中起作用。这与当前一刀切（one-size-fits-all）的传统方法形成对比，目前的传统方法对于疾病治疗和预防策略是为所有人制定的，而较少考虑个体之间的差异。
Precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a one-size-fits-all approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.
药物基因组学是精准医学的一部分。药物基因组学是研究基因如何影响人对特定药物的反应的研究。这个相对较新的领域结合了药理学（药物科学）和基因组学（基因及其功能的研究），以量体裁衣的方式去开发适合每个人因基因的不同而应对的有效、安全的药物和剂量。
Pharmacogenomics is a part of precision medicine. Pharmacogenomics is the study of how genes affect a person's response to particular drugs. This relatively new field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications and doses that are tailored to variations in a person's genes.
个性化药物的主要障碍在于其高昂的成本。而利用植物瞬时表达技术可以大规模降低成本，加快个人药物定制的进程。利用基因组学、蛋白组学技术，找出相关恶性疾病基因，利用我们的植物瞬时技术表达特定蛋白，在实验室的条件下纯化出来供个人使用的药物，整个过程在两个月内即可完成。
The main obstacle to personalized medicine is its high cost. The use of plant transient expression technology can reduce costs on a large scale and accelerate the process of personized drug. Using genomics and proteomics techniques to identify genes related to malignant diseases, we can express specific-diseased related proteins, and purify the drugs for personal use under laboratory conditions. The whole process can be completed within two months.
